| # | Drug | Count |
|---|---|---|
| 0 | BLINATUMOMAB | 1 |
| 1 | CANDESARTAN | 1 |
| 2 | CYTARABINE | 1 |
| 3 | DAPAGLIFLOZIN | 1 |
| 4 | FINASTERIDE | 1 |
| 5 | IVOSIDENIB | 1 |
| 6 | IXEKIZUMAB | 1 |
| 7 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 1 |
| 8 | REVUMENIB | 1 |
| 9 | SECUKINUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REVUMENIB | 1 | 0.0010 |
| 1 | IVOSIDENIB | 1 | 0.0005 |
| 2 | BLINATUMOMAB | 1 | 0.0001 |
| 3 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0001 |
| 4 | CANDESARTAN | 1 | 0.0000 |
| 5 | IXEKIZUMAB | 1 | 0.0000 |
| 6 | SUNITINIB MALATE | 1 | 0.0000 |
| 7 | DAPAGLIFLOZIN | 1 | 0.0000 |
| 8 | CYTARABINE | 1 | 0.0000 |
| 9 | FINASTERIDE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | 5-alpha Reductase Inhibitor [EPC] | 1 |
| 1 | Interleukin-17A Antagonist [EPC] | 1 |
| 2 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 1 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 2 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |